JOHN MIHELCIC: Open Payments
NPI 1134582521 · PEORIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 49 payments from 15 companies in 2025. Trend: 2023 $360 · 2024 $757 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $190 |
| Indivior Inc. | 7 | $141 |
| E.R. Squibb & Sons, L.L.C. | 4 | $127 |
| GENZYME CORPORATION | 1 | $95 |
| Gilead Sciences, Inc. | 4 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Alkermes, Inc. | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $45 |
Products named: VRAYLAR, SUBLOCADE, COBENFY, CABLIVI, ARISTADA, REXULTI, CAPLYTA, INGREZZA.
Industry payments across IL — which companies pay providers there.
